These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20718413)

  • 1. Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (-)-epigallocatechin-3-gallate.
    Wang SH; Liu FF; Dong XY; Sun Y
    J Phys Chem B; 2010 Sep; 114(35):11576-83. PubMed ID: 20718413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic analysis of the molecular interactions between amyloid β-protein fragments and (-)-epigallocatechin-3-gallate.
    Wang SH; Dong XY; Sun Y
    J Phys Chem B; 2012 May; 116(20):5803-9. PubMed ID: 22536844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations.
    Liu FF; Dong XY; He L; Middelberg AP; Sun Y
    J Phys Chem B; 2011 Oct; 115(41):11879-87. PubMed ID: 21899367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ
    Zhan C; Chen Y; Tang Y; Wei G
    ACS Chem Neurosci; 2020 Jun; 11(12):1841-1851. PubMed ID: 32441920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study.
    Bora RP; Prabhakar R
    Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.
    Li X; Zhang Y; Wang Y; Zhang S; Zhang L
    J Phys Chem B; 2024 Feb; 128(8):1843-1853. PubMed ID: 38359305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Molecular Mechanisms of EGCG and Apigenin on Disrupting Amyloid-Beta Protofibrils Based on Molecular Dynamics Simulations.
    Fang M; Zhang Q; Guan P; Su K; Wang X; Hu X
    J Phys Chem B; 2022 Oct; 126(41):8155-8165. PubMed ID: 36219848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ(1-42) dimer.
    Zhang T; Zhang J; Derreumaux P; Mu Y
    J Phys Chem B; 2013 Apr; 117(15):3993-4002. PubMed ID: 23537203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper.
    Zhang B; Cheng XR; da Silva IS; Hung VW; Veloso AJ; Angnes L; Kerman K
    Metallomics; 2013 Mar; 5(3):259-64. PubMed ID: 23443273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity inhibitors protect lipid membranes from disruption by Aβ42.
    Malishev R; Nandi S; Kolusheva S; Levi-Kalisman Y; Klärner FG; Schrader T; Bitan G; Jelinek R
    ACS Chem Neurosci; 2015 Nov; 6(11):1860-9. PubMed ID: 26317327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
    Saraiva AM; Pereira MC; Brezesinski G
    Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and theoretical studies on the binding of epigallocatechin gallate to purified porcine gastric mucin.
    Zhao Y; Chen L; Yakubov G; Aminiafshar T; Han L; Lian G
    J Phys Chem B; 2012 Nov; 116(43):13010-6. PubMed ID: 22506496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses.
    Lin MS; Chen LY; Tsai HT; Wang SS; Chang Y; Higuchi A; Chen WY
    Langmuir; 2008 Jun; 24(11):5802-8. PubMed ID: 18452319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding interactions of (-)-epigallocatechin-3-gallate from green tea and lipase.
    Wu X; He W; Yao L; Zhang H; Liu Z; Wang W; Ye Y; Cao J
    J Agric Food Chem; 2013 Sep; 61(37):8829-35. PubMed ID: 23971865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.